3
Announcements
Trials
Browse
Landscape
Status
Completed
8
Recruiting
6
Active not recruiting
5
Withdrawn
4
Terminated
3
Unknown
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Amyloidosis
1
Interventions
venetoclax
1
selinexor
1
idecabtagene vicleucel
1
belantamab mafodotin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Available
×
Multiple Myeloma
×
venetoclax
×
Clear all
NCT03123029
2026-01-30
Expanded Access to Venetoclax
AbbVie
Available